ES533842A0 - Un procedimiento para la obtencion de derivados de amino-pirimidina - Google Patents

Un procedimiento para la obtencion de derivados de amino-pirimidina

Info

Publication number
ES533842A0
ES533842A0 ES533842A ES533842A ES533842A0 ES 533842 A0 ES533842 A0 ES 533842A0 ES 533842 A ES533842 A ES 533842A ES 533842 A ES533842 A ES 533842A ES 533842 A0 ES533842 A0 ES 533842A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining amino
pirimidine derivatives
pirimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533842A
Other languages
English (en)
Other versions
ES8602694A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/509,886 external-priority patent/US4505910A/en
Priority claimed from US06/509,887 external-priority patent/US4507304A/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES533842A0 publication Critical patent/ES533842A0/es
Publication of ES8602694A1 publication Critical patent/ES8602694A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES533842A 1983-06-30 1984-06-29 Un procedimiento para la obtencion de derivados de amino-pirimidina Expired ES8602694A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/509,886 US4505910A (en) 1983-06-30 1983-06-30 Amino-pyrimidine derivatives, compositions and use
US06/509,887 US4507304A (en) 1983-06-30 1983-06-30 Use of 6-amino-5-pyrimidinecarbonitrile derivatives as cardiotonic agents

Publications (2)

Publication Number Publication Date
ES533842A0 true ES533842A0 (es) 1985-12-01
ES8602694A1 ES8602694A1 (es) 1985-12-01

Family

ID=27056692

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533842A Expired ES8602694A1 (es) 1983-06-30 1984-06-29 Un procedimiento para la obtencion de derivados de amino-pirimidina

Country Status (11)

Country Link
EP (1) EP0130735B1 (es)
KR (1) KR900001180B1 (es)
AU (1) AU572856B2 (es)
CA (1) CA1232905A (es)
DE (1) DE3474913D1 (es)
DK (1) DK309084A (es)
ES (1) ES8602694A1 (es)
GR (1) GR82004B (es)
HU (1) HU193581B (es)
IE (1) IE57728B1 (es)
PH (1) PH21577A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617393A (en) * 1985-07-19 1986-10-14 American Home Products Corporation 5-substituted-6-aminopyrimidines, composition and uses as cardiotonic agents for increasing cardiac contractility
EP0530149A1 (de) * 1991-08-30 1993-03-03 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
DE10238724A1 (de) 2002-08-23 2004-03-04 Bayer Ag Alkyl-substituierte Pyrazolpyrimidine
DE10238723A1 (de) 2002-08-23 2004-03-11 Bayer Ag Phenyl-substituierte Pyrazolyprimidine
DE10238722A1 (de) 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
WO2004080979A1 (en) * 2003-03-14 2004-09-23 Lg Life Sciences Ltd. Novel 3-(2-amino-4-pyrimidinyl)-4-hydroxyphenyl ketone derivatives
US8044060B2 (en) 2003-05-09 2011-10-25 Boehringer Ingelheim International Gmbh 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
DE10320785A1 (de) 2003-05-09 2004-11-25 Bayer Healthcare Ag 6-Arylmethyl-substituierte Pyrazolopyrimidine
DE10328479A1 (de) 2003-06-25 2005-01-13 Bayer Ag 6-Arylamino-5-cyano-4-pyrimidinone
DE102004001873A1 (de) * 2004-01-14 2005-09-29 Bayer Healthcare Ag Cyanopyrimidinone
DE102005024494A1 (de) * 2005-05-27 2006-11-30 Bayer Healthcare Ag Verwendung von Cyanopyrimidinen
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
US8648085B2 (en) 2007-11-30 2014-02-11 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
AP2011005672A0 (en) 2008-09-08 2011-04-30 Boehringer Ingelheim Int Pyrazolopyrimidines and their use for the treatment of CNS disorders.
NZ594567A (en) 2009-03-31 2013-12-20 Boehringer Ingelheim Int 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
WO2012020022A1 (en) 2010-08-12 2012-02-16 Boehringer Ingelheim International Gmbh 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD72790A (es) *
GB932674A (en) * 1961-02-03 1963-07-31 Ici Ltd Veterinary growth promoting compositions comprising pyrimidines
AU502739B2 (en) * 1977-03-02 1979-08-09 The Wellcome Foundation Limited Biologically active compounds and compositions
IT1092343B (it) * 1978-02-02 1985-07-06 Poli Ind Chimica Spa Pirimidilsolfuri ad attivita' antisecretoria,processo per la loro preparazione e composizioni farmaceutiche che li contengono
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them

Also Published As

Publication number Publication date
KR900001180B1 (ko) 1990-02-27
IE841569L (en) 1984-12-30
EP0130735A1 (en) 1985-01-09
DK309084D0 (da) 1984-06-25
EP0130735B1 (en) 1988-11-02
AU2971084A (en) 1985-01-03
HU193581B (en) 1987-10-28
ES8602694A1 (es) 1985-12-01
GR82004B (es) 1984-12-12
CA1232905A (en) 1988-02-16
DE3474913D1 (en) 1988-12-08
AU572856B2 (en) 1988-05-19
PH21577A (en) 1987-12-11
DK309084A (da) 1984-12-31
HUT34465A (en) 1985-03-28
KR850000413A (ko) 1985-02-27
IE57728B1 (en) 1993-03-24

Similar Documents

Publication Publication Date Title
ES540812A0 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES542202A0 (es) Procedimiento para la obtencion de un derivado de nitrometi-leno
ES546916A0 (es) Un procedimiento para preparar derivados de guanina
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES541229A0 (es) Un procedimiento para la preparacion de nuevos derivados delcromano
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES533842A0 (es) Un procedimiento para la obtencion de derivados de amino-pirimidina
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES545270A0 (es) Un procedimiento para la obtencion de piridoindoles
ES544140A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES533673A0 (es) Procedimiento para la obtencion de un derivado de fenilsulfonilguanidina
ES532172A0 (es) Un procedimiento para la preparacion de derivados de pirimidona
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES525007A0 (es) Un procedimiento para producir derivados de tiazol
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES546356A0 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
ES545777A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES541840A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolilo
ES539429A0 (es) Procedimiento para la obtencion de un derivado de sulfonilguanidina
ES535951A0 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303